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OBJECTIVES: To evaluate the effects of Urtica dioica on hepatic ischemia-reperfusion injury.
METHODS: Thirty adult male Wistar albino rats were divided into three groups: sham group (group 1), control
group (group 2), and Urtica dioica group (group 3). All the rats were exposed to hepatic ischemia for 60 min,
followed by 60 min of reperfusion. In group 2, a total of 2 ml/kg 0.9% saline solution was given intraperitoneally. In
group 3, a total of 2 ml/kg Urtica dioica was given intraperitoneally. At the end of the procedure, liver tissue and
blood samples were taken from all rats. Serum aspartate aminotransferase, alanine aminotransferase, lactate
dehydrogenase, ceruloplasmin, catalase, paraoxonase, arylesterase, and lipid hydroperoxide levels were measured.
Liver tissue histopathologies were also evaluated by light microscopy.
RESULTS: Serum aspartate aminotransferase, alanine aminotransferase and lactate dehydrogenase levels were
significantly higher in group 2 than in group 1, and significantly lower in group 3 than in group 2. Also, group 2 had
higher serum lipid hydroperoxides and ceruloplasmin levels but lower catalase, paraoxonase, and arylesterase levels
than group 1. In group 3, serum lipid hydroperoxides and ceruloplasmin levels were significantly lower, and
catalase, paraoxonase, and arylesterase levels were higher than those in group 2. Histopathological examination
showed that liver tissue damage was significantly decreased in group 3 compared with group 2.
CONCLUSIONS: Urtica dioica has a protective effect on the liver in hepatic ischemia-reperfusion-injured rats.
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INTRODUCTION
Ischemia-reperfusion (IR) injury is cellular damage that
causes the release of toxic metabolites and several inflam-
matory substances into the systemic circulation.
1,2 When the
ischemic tissue is reperfused, there may be more severe
damage than the ischemic injury itself. An acute inflamma-
tory response is the basis of the physiopathology of IR
injury. Complex mechanisms such as emerging free oxygen
radicals and leukocyte aggregation cause cellular death,
organ dysfunction, and, finally, organ failure.
3,4
Many studies of plants and drugs illustrate their pro-
tective antioxidant and anti-inflammatory effects on IR
injury. One such plant is Urtica dioica (UD)–a common green
plant that grows all over the world. From long ago to the
present day, it has been used in many different applications,
such as alternative medicine, food, paint, fiber, manure and
cosmetics.
5 In addition, studies have shown that UD has
antimicrobial, anti-inflammatory, analgesic, and antioxidant
effects.
6-8
This study aimed to examine the biochemical and histo-
pathological effects of UD on hepatic IR injury in rats.
METHODS
UD Ethereal Oil Isolation
UD seeds were collected by a botanist, converted to
granules in an electrical grinder, and added to diethyl ether.
After half an hour’s extraction, the mixture was filtered. The
filtrate was separated from the ether with a rotary evapo-
rator under vacuum, and the etheric oil extract was collec-
ted. The extract was centrifuged at 4,000 rpm for 15 minutes,
then the grounds at the bottom of the tube were removed,
and the remaining clear fluid was used in this study.
6,9,10
Animal Experiments
This study was approved by the local ethics board in
Duzce University Faculty of Medicine, Experimental
Animals Laboratory, in 2009. (DU Ethics Committee
Number: 2009-18). For the study, 30 adult male Wistar
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1357albino rats from the same colony, ranging in weight from
200 to 230 g were used. The rats were cared for in
accordance with the Guide for the Care and Use of
Laboratory Animals. Rats were given standard rat food
and pipe water, with a 12 h light/12 h dark rhythm, in a
room at a temperature of 22¡2˚C.
Rats were divided at random into three groups containing
10 rats each: a sham group (group 1), control group (group
2), and Urtica dioica group (group 3). All rats were anesthe-
tized by the administration of ketamine hydrochloride
(Ketalar; Parke Davis, Eczacibasi, Istanbul) 50 mg/kg
intramuscularly and xylazine hydrochloride (Rompun;
Bayer AG, Leverkusen, Germany) 3 mg/kg/ intramuscu-
larly. During the operations, additional doses were admi-
nistered if necessary.
The operation was performed with the rats in a supine
position; the abdominal front wall was shaved and disin-
fected using povidone-iodine 10%. Laparotomy was carried
out oneach ratwith midline incision. Group 1 wasgiven only
laparotomy; the other groups were given hepatic ischemia
andreperfusion.Thehepatic artery, portal vein,andcommon
bile duct were clamped with microvascular bulldog clamps
in order to achieve ischemia. After 60 min ischemia, the
clamps were opened, and reperfusion was allowed for
60 min. In group 2, a total of 2 ml/kg 0.9% saline solution
(1 ml/kg before ischemia and 1 ml/kg after reperfusion) was
given intraperitoneally. In group 3, a total of 2 ml/kg UD
(1 ml/kg before ischemia and 1 ml/kg after reperfusion) was
given intraperitoneally. At the end of the procedure, liver
tissue samples and blood samples were collected from all the
rats. Then, the rats were sacrificed by intraperitoneal
administration of lethal ketamine hydrochloride.
Liver tissue samples were divided into two. One part was
used for histopathological evaluation, and the other for the
detection of catalase activity. The tissues, for catalase
analysis, were homogenized in a homogenizer (Omni TH
International, USA). After centrifugation at 10,000 g for
about 60 min, the upper clear layer was taken. The
homogenate was divided into aliquots. The homogenate
aliquots and serum samples were stored for 3 months at
280˚C until biochemically analyzed.
Biochemical Analysis
Serum aspartate aminotransferase (AST), alanine amino-
transferase (ALT), lactate dehydrogenase (LDH), and cer-
uloplasmin levels were measured in serum samples of rats
using the commercial kit, Abbott Architect C–8000 Auto-
analyzer (Abbott Laboratories, USA). The determination of
ceruloplasmin is based on the specific immunoturbidimetric
reaction which occurs between the anticeruloplasmin poly-
clonal antiserum and its corresponding antigen under
optimal pH conditions and in the presence of polyethylene
glycol. The turbidity of the immunocomplex is proportional
to the concentration of the analyte in the sample.
Catalase activity in liver tissue was measured in the
supernatant at 20˚C according to the method of Aebi.
11 A
molar extinction coefficient of 43.6 M
-1 cm
-1 was used, and
the rate of the first 30 s was used to calculate the activity.
Catalase activity was expressed as U/mg protein. Protein
was identified by the Bradford method.
12
Serum paraoxonase (PON1) activity was determined by
spectrophotometric measurement of the colored product 4-
nitrophenol, which was formed by enzymatic hydrolysis of
paraoxonase used as substrate (O,O-diethyl-O-p-nitrophenyl
phosphate; Sigma Co, London, UK). Arylesterase (ARE)
activity was determined by spectrophotometric measure-
ment of the colored phenol product formed by enzymatic
hydrolysis of phenylacetate (Sigma).
13 One unit (U) was
defined as 1 nmol 4-nitrophenol/L serum/min for PON1
activity and 1 mmol phenol/ml serum/min for ARE activity.
The tri-iodide complex, which was formed by reaction
between lipid hydroperoxides (LOOH) and iodide was
spectrophotometrically evaluated at a wavelength of 365 nm.
The tri-iodide extinction coefficient (e = 2.46610
4 M
-1 cm
-1)
was used to calculate the results. We used butylated
hydroxytoluene (BHT) as an antioxidant according to
Gorog et al.
14
Spectrometric measurements were carried out with a Stat
Fax spectrophotometer (Awareness Technology, USA).
Histopathological Evaluation
For histopathological examination, the liver tissues were
dissected and the tissue samples fixed in Zenker solution for
24 h, processed using a graded ethanol series, and embed-
ded in paraffin. The paraffin sections were cut into 4 mm
thick slices and stained with hematoxylin and eosin for
light microscopic examination. The sections were viewed
and photographed using an Olympus light microscope
(Olympus BX51, Tokyo, Japan) with an attached photo-
graphic machine (Olympus E–330, Olympus Optical Co.
Ltd, Japan). Ten slides were prepared from each liver. All
sections were evaluated for the degree of portal inflamma-
tion, necrosis, vacuolar degeneration, sinusoidal dilatation,
and vascular congestion. Each liver slide was examined, and
the severity of the changes observed was scored using a
scale of none [0], mild [1], moderate [2], and severe [3]
damage. Histopathological evaluation was made by an
experienced pathologist.
15
Statistical Analysis
Complete measured information was assessed using SPSS
11.5 (Statistical Package for Social Science). Data were given
as mean¡standard deviation. One way analysis of variance
(post hoc Bonferroni test) was used in multiple group
analysis, a t-test was used to compare two independent
groups, x
2 (Fisher’s exact) test was used for categorical data
analysis, and p,0.05 was accepted as statistically signifi-
cant.
RESULTS
Biochemical Findings
Biochemical findings of the study are shown in Table 1.
Serum AST, ALT, and LDH levels were significantly higher
in group 2 than in group 1 (p,0.0001), and significantly
lower in group 3 than in group 2 (p,0.0001).
Serum LOOH and ceruloplasmin levels in group 2 were
significantly higher than in group 1 (respectively, p=0.001
and p=0.02). However, serum arylesterase, paraoxonase,
and liver tissue catalase in group 2 activity were also
significantly lower than in group 1 (p,0.0001, p=0.02, and
p=0.02, respectively).
Serum LOOH and ceruloplasmin levels in group 3 were
lower than in group 2; however, only ceruloplasmin was
statistically significant (p=0.04). A statistically significant
increase was found in serum arylesterase, paraoxonase, and
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1358liver tissue catalase activity in group 3 in comparison with
group 2 (p=0.01, p=0.03, and p=0.01, respectively).
Histopathological Findings
Histopathological findings of the study are shown in
Table 2. This evaluation showed that there were no patho-
logical changes in liver tissues of group 1. There was no
necrosis, congestion, or inflammation findings (HE 6200)
(Figure 1A). Hepatocyte necrosis and congestion of the
sinusoids and central vein were evident in group 2 (HE
6200) (Figure 1B). There was minimal central vein conges-
tion in hepatic lobules in group 3. Hepatocytes of group 3
appeared the same as those of group 1 (HE 6200)
(Figure 1C). In addition, tissue damage in group 3 was
lower than that in group 2.
DISCUSSION
This study underlines three points: (1) the emergence of
free oxygen radicals that arise after hepatic IR and cause
injury can be prevented by UD; (2) the increase in AST, ALT,
and LDH—an indication of tissue damage in hepatic IR
injury—is less after UD treatment; (3) in the early stages of
hepatic IR injury, histopathological examination of liver
tissue shows considerably less hepatocyte injury with UD
treatment.
Free oxygen radicals have a marked mediator role in IR
injuries of several organs, including the liver.
16-18 Some
research suggests that antioxidant molecules may provide
protection from IR injury.
16,19-21 UD is known to be a strong
antioxidant, breaking up free radicals. For this reason, it is
expected to be protective in hepatic IR injury of rats.
6-8
Studies of UD have used different doses and methods of
application. No standard dose has been agreed. UD is given
internally in most of the studies.
9,22 We used a total dose of
2 ml/kg administered intraperitoneally.
6,9,10 To decrease IR
injury, some studies have given the drug only before
ischemia or after reperfusion, but others have given the
drug for both ischemia and reperfusion.
6,16,23 In our study
Table 1 - Biochemical markers in groups.
Groups
Parameters Group 1 (sham) n=10 Group 2 (control) n=10 Group 3 (UD) n=10
LOOH (mmol/mL)* 23.0¡4.5 29.9¡3.2 27.0¡4.3
Ceruloplasmin (mg/dL){ 16.7¡2.2 20.3¡4.4 16.0¡3.9
Arylesterase (U/L){ 168.3¡19.4 87.5¡47.5 133.7¡45.6
Paraoxonase (U/L)1 38.8¡15.2 20.5¡17.1 31.9¡21.1
Liver catalase (U/mg protein)" 54.5¡12.0 43.3¡9.6 54.0¡7.7
AST (U/L)** 125.4¡19.9 907.2¡205.1 444.2¡78.8
ALT (U/L)** 79.8¡12.9 636.8¡139.7 246.5¡87.5
LDH (U/L)** 481.8¡78.5 4098.9¡496.3 1760.7¡978.3
*Group 1 vs. group 2, p=0.001; however, group 1 vs. group 3 and group 2 vs. group 3, NS.
{Group 1 vs. group 2, p=0.02, and group 2 vs. group 3, p=0.04; however, group 1 vs. group 3, NS.
{Group 1 vs. group 2, p,0.0001 and group 2 vs. group 3, p=0.01; however, group 1 vs. group 3, NS.
1Group 1 vs. group 2, p=0.02 and group 2 vs. group 3, p=0.03; however, group 1 vs. group 3, NS.
"Group 1 vs. group 2, p=0.02 and group 2 vs. group 3, p=0.01; however, group 1 vs. group 3, NS.
**Group 1 vs. group 2, group 1 vs. group 3, and group 2 vs. group 3, all p,0.0001.
ALT, alanine aminotransferase; AST, aspartate aminotransferase; JDH, lactate dehydrogenase; LOOH, lipid hydroperoxides; UD, Urtica dioica.
Table 2 - Median histological injury scores* of liver tissue.
Groups
Parameters
Group 1
(sham) n=10
Group 2
(control) n=10
Group 3
(UD) n=10
Portal inflammation 02 0
Necrosis 03 0
Vacuolar degeneration 02 0
Sinusoidal dilatation 01 1
Vascular congestion 02 1
*Scale: none [0], mild [1], moderate [2], and severe [3] damage.
UD, Urtica dioica.
Figure 1 - (A) In group 1, normal liver tissue was observed on histopathological examination (hematoxylin–eosin, original magnification
6200); (B) in group 2, hepatocyte necrosis and congestion of the sinusoids and central vein on liver tissue were seen (hematoxylin–
eosin, original magnification 6200); (C) in group 3, minimal central vein congestion in hepatic lobules and significantly less tissue
damage on hepatocytes were seen (hematoxylin–eosin, original magnification 6200).
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1359we preferred to use 2 ml/kg UD (1 ml/kg before ischemia
and 1 ml/kg after reperfusion). Our aim was to benefit from
a prophylactic effect by attempting to reach a definite
plasma level of UD before creating ischemia and to detect
the protective effect on immediate damage that will occur
after reperfusion.
Many studies on the effects of UD on the liver have been
reported but most describe liver toxicity achieved by toxic
substances.
9,24 In this study, the protective effect of UD was
examined after IR injury had occurred.
In IR injury of the liver during the reperfusion phase,
emerging reactive oxygen radicals activate some mediators
and can cause inflammatory response and tissue damage.
For this reason AST, ALT, and LDH activities may
increase.
16,25 The increase of AST, ALT, and LDH activities
in group 2 of our study supports this finding. In this study,
it is shown that in group 3, ALT, AST, and LDH enzymes,
markers of liver parenchymal injury, have decreased levels
in comparison with group 2 (p,0.0001). This finding
supports the protective effect of UD treatment on IR injury.
Oxidative stress occurs particularly in reperfusion after
ischemia. Synthesis of proinflammatory cytokines and cell
adhesion molecules is activated, and the inflammatory
response is increased by oxidative stress. The antioxidant
system has an important role in protection from the damage
of oxidative stress.
16,21,23,26 In our study, by measuring the
liver tissue catalase, paraoxonase, arylesterase, ceruloplas-
min, and lipid hydroperoxide levels, we obtained informa-
tion about hepatic IR injury. Catalase is an antioxidant
enzyme that catalyses the change from hydrogen peroxide
into water. Paraoxonase and arylesterase are similar gene-
coded enzymes that have similar active centers. Paraoxonase
enzyme shows antioxidant activity by protecting LDL from
oxidation and neutralizing free radicals, including hydrogen
peroxide.
13,27,28 In this study, UD increased the activity of
paraoxonase, arylesterase, and liver tissue catalase activity,
supporting the protective effect of UD.
Ceruloplasmin, has a molecular mass of 125 kDa, and its
antioxidant effect may depend on ferroxidase activity,
ascorbate oxidase activity, O2 scavenging activity, and
glutathione-dependent peroxidase activity. Oxygen is
directly reduced to water in a redox reaction and may be
the mechanism by which ceruloplasmin inhibits super-
oxide-induced lipid peroxidation. Therefore, elevated
serum ceruloplasmin levels could signal abnormally high
oxidant stress.
29 In our study, the ceruloplasmin level was
significantly elevated in group 2. These findings are
evidence that effective hepatic IR injury and oxidative stress
was created in group 2. In group 3, ceruloplasmin levels fell
until they reached almost the same level as those of the
control group, suggesting that treatment with UD reduced
oxidative stress resulting in a decrease in ceruloplasmin
levels.
Lipid hydroperoxide is an intermediate free radical
oxidant that is synthesized during lipid peroxidation.
30,31
In our study, lipid hydroperoxide levels were found to be
significantly higher in group 2 than group 1. Also, it was
found that treatment with UD in group 3 decreased the lipid
hydroperoxide activity, indicating that the antioxidant effect
of UD had prevented the emergence of an oxidant agent
such as LOOH with creation of hepatic IR.
A histopathological examination detected no patholo-
gical changes in group 1. Particularly severe necrosis, mode-
rate inflammation, vacuolar degeneration, and vascular
congestion were seen in group 2. Examination of group 3
showed that the pathological changes existing in group 2
had almost completely disappeared. These results indicate
that UD has a protective effect on hepatic damage created
with IR.
This study had some limitations. Because of the study
protocol, hepatic IR-injured rats were sacrificed just after
reperfusion in order to observe the early effects of UD. If we
could have kept the rats alive, we could also have observed
the long-term effects of UD in hepatic IR injury. We expect
that further studies on the long-term effects of UD will
increase the value of our positive findings. In addition, it is
important to examine the possible ability of UD to reverse
IR-induced damage in liver tissue and its effects on levels of
antioxidant enzymes.
In conclusion, it was found that UD increased the antio-
xidant ability and decreased oxygen free radicals in the
early period of hepatic IR injury in rats. Also, evaluation of
liver enzymes and histopathological findings of liver tissue
indicated that UD had beneficial effects on the liver, so UD
can be considered a preventive treatment agent in hepatic IR
injury. As this study does not contain information about the
long-term results of UD treatment of hepatic IR injury,
further experimental and clinical studies are needed. These
views should be re-examined in light of the results obtained
from clinical phase 1 and phase 2 studies in which UD is
administered to humans.
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